From Trump's 100 per cent pharma tariff to RBI's stance on repo rates, here's what made headlines
01-Nov-2025•Value Research Team
Welcome to the New Value Research!
2 min read•By Value Research
One global fund reopens to new SIPs
5 min read•By Aakar Rastogi
Rentomojo IPO: Real profits, rich price
6 min read•By Lekisha Katyal